STAT+: Canada’s drug makers rattle their sabers over a government plan to control medicine spending
A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug…
Category: Pharmaceuticals
STAT+: Biotech’s presence on new social media app Clubhouse is growing
For years, Twitter has been biotech’s social media app of choice. But the industry appears…
Virtual Event: STAT@JPM: Facing 2021
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019
During 2019, drug makers raised prices on seven widely used medicines by substantial amounts without…
STAT+: Company dedicated to cutting drug prices raises lots of money, releases few details
EQRx, a startup that made waves last year when it announced a plan to develop…
STAT+: FDA advisory panel meetings became ‘rarer and tougher’ in 2020
Among the myriad changes wrought by the Covid-19 pandemic, Food and Drug Administration advisory committee…
STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first…
STAT+: Pharma rings in the new year with 5% price hikes on hundreds of medicines
When it comes to prescription drug prices, what goes up often continues to go up…
STAT+: HHS rebukes drug makers for curtailing discounts to hospitals that serve low-income communities
After months of controversy, the Department of Health and Human Services issued a stern rebuke…
Opinion: Looking back and looking ahead: Vioxx, drug safety, and the legacy of Sen. Michael Enzi
The prescription painkiller originally known as Vioxx may be making a comeback after its maker,…
STAT+: Kulkarni victorious in best biopharma CEO vote; Leschly tops worst list
The best and worst biopharma CEOs of 2020, selected by STAT+ readers, are Sam Kulkarni…
STAT+: AbbVie wins 21 months of wrinkle-free competition for Botox thanks to an ITC ruling
In a victory for AbbVie (ABBV), the U.S. International Trade Commission decided that imports of…
STAT+: Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’
Although the opioid crisis in the U.S. continues to make headlines, a new analysis finds…
STAT+: Here are the nominees for worst biopharma CEO of 2020
I told my editor that writing the worst CEOs of biopharma column is one of…
.jpg)
STAT+: Here are the nominees for best biopharma CEO of 2020
A year like no other requires a new way of drafting a list of Best…
STAT+: AstraZeneca to acquire Alexion for $39 billion, adding blockbuster immune medicines
AstraZeneca on Saturday said it was acquiring Alexion Pharmaceuticals for $39 billion, marking a significant…
Opinion: STAT+: In biopharma mergers and acquisitions, managing regulatory compliance early protects return on investment
Mergers and acquisitions have long been a vehicle for growth in the pharmaceutical industry. They…
STAT+: Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
In a blow to pharmacy benefit managers, the U.S. Supreme Court ruled that an Arkansas…
STAT+: Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
As states struggle to control the cost of prescription medicines, a new report found pharmacy…
STAT+: J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
More than three-quarters of the multiple myeloma patients treated with an experimental CAR-T therapy from…
Opinion: Misguided federal regulations are likely to cause more pain in people already living with it
Hidden in the shadows of the Covid-19 pandemic is the U.S.’s drug epidemic, which is…
STAT+: STAT+ Conversations: A conversation on drug pricing, policy, and access
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma and health tech…
Opinion: The U.S. must support access to care and incentives for the innovation that transforms it
The deadly spread of Covid-19 around the world has highlighted the importance of innovation and…
STAT+: ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
On the evening that would jolt the global traffic of cancer treatments, David Kim was…
STAT+: How Amazon Pharmacy could ramp up pressure on the prescription drug industry
The launch of Amazon Pharmacy on Tuesday sent shockwaves through the pharmacy pipeline, with industry…
STAT+: FDA vows to disclose data used to support emergency drug authorizations
In response to blistering criticism, the Food and Drug Administration committed to publicly disclosing reviews…
STAT+: Amazon, expanding its growing health empire, launches Amazon Pharmacy
Amazon added new territory to its burgeoning health care empire on Tuesday, launching Amazon Pharmacy,…
‘You just got better at making money’: Democrats blast Celgene, Teva for price hikes detailed in internal documents
WASHINGTON — A handful of newly elected Democrats, including Rashida Tlaib of Michigan, Ayanna Pressley…
Congressional investigation reveals Celegene, Teva plotted to keep drug prices high
WASHINGTON — The House Oversight Committee released two major reports Wednesday that expose the internal…
STAT Plus: Telehealth startup Ro expands partnership with Pfizer to provide generic drugs
Telehealth startup Ro is expanding its partnership with pharma giant Pfizer’s generics arm to offer…
Regeneron’s Covid-19 antibody may help non-hospitalized patients recover faster, early data show
New data from the biotechnology firm Regeneron seem likely to add to the excitement about…
STAT Plus: STAT+ Conversations: How Covid-19 will change drug development
Editor’s note: A live stream of the conversation will be embedded below at 1 p.m….
STAT Plus: Drug industry CEOs will testify this week about some of pharma’s most controversial medicines
The House Oversight Committee will hold two days of hearings this week with six drug…
STAT Plus: An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame
A mandated safety program regulators rely on to minimize opioid abuse and misuse is not…
STAT Plus: With a new law, California becomes the first state to pursue its own line of generics
In a groundbreaking move, California adopted a law Monday to allow the state to develop…
.jpg)
Opinion: Global investors must support pharma solidarity and collaboration in the response to Covid-19
The prospect of having the first supplies of at least a few effective Covid-19 medicines…
New research finds unapproved drugs in brain-boosting supplements
The supplement aisle is rife with “nootropics,” “smart drugs” and “cognitive enhancers” that claim to…
STAT+ Conversations: The D.C. Diagnosis
Each week, STAT Plus subscribers get exclusive access to live discussions with STAT reporters and…
STAT Plus: The world is racing toward Covid-19 drugs. In normal times, it takes years to get new antivirals out the door
Researchers may be racing to develop new Covid-19 treatments, but normally it has taken slightly…
STAT Plus: New drug combination extends survival with advanced kidney cancer. It’s poised to enter a competitive treatment market
Patients with advanced kidney cancer live longer when treated with a combination of drugs from…
STAT Plus: FDA warns Sprout for failing to mention risks in radio ad for Addyi
The Food and Drug Administration has admonished Sprout Pharmaceuticals for running a radio ad that…
STAT Plus: U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions
When it comes to delivering prescription drugs to Americans, the U.S. Postal Service may as…
STAT Plus: Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future
An experimental pill from Merck reduced the frequency of chronic coughing enough to achieve the…
Amid broad mistrust of FDA and Trump administration, drug companies seek to reassure public about Covid-19 vaccine safety
WASHINGTON — A group of nine leading pharmaceutical and biotechnology companies pledged on Tuesday to…
Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to
Talk about a rebuke. President Trump may want a Covid-19 vaccine to ship in time…
STAT Plus: ‘The race is on’: China’s I-Mab gets boost from AbbVie to develop a new cancer immunotherapy
HONG KONG — In November 2014, a little less than six years ago, Chinese scientist…
STAT Plus: U.S. authorities expected to file charges against Teva in generic price fixing probe
Federal prosecutors reportedly plan to charge Teva Pharmaceuticals (TEVA) of conspiring with other manufacturers of…
STAT Plus: Sun Pharma unit to pay $21 million for giving docs false instructions for an acne treatment
A unit of Sun Pharmaceuticals agreed to pay nearly $21 million to settle allegations of…
STAT Plus: Pharmacists say they tell patients about physical changes to pills, but consumers say that isn’t always the case
Most consumers say they aren’t notified of physical changes in their prescription pills, even though…
STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
A growing number of drug makers are taking steps to curtail the discounts they offer…